Alzheimer's disease (AD) is a chronic neurodegenerative disease, with the characteristics of
neurofibrillary tangle (NFT) and senile plaque (SP) formation. Although great progresses …

Alzheimer's disease (AD) is a debilitating neurological disorder, and currently, there is no
cure for it. Several pathologic alterations have been described in the brain of AD patients …

The inflammasome regulates innate immunity by serving as a signaling platform. The Nod‑
like receptor protein 3 (NLRP3) inflammasome, equipped with NLRP3, the adaptor protein …

Despite the introduction of vaccines and drugs for SARS-CoV-2, the COVID-19 pandemic
continues to spread throughout the world. In severe COVID-19 patients, elevated levels of …

In recent years, there has been increasing research interest in the correlation between
hearing impairment and cognitive decline, two conditions that have demonstrated a strong …

Neuroinflammation is one of the core pathological features of Alzheimer's disease (AD) as
both amyloid β (Aβ) and tau monomers and oligomers can trigger the long-term pro …

Aging is associated with the occurrence of diverse degenerative changes in various tissues
and organs and with an increased incidence of neurological disorders, especially …

(1) Alzheimer's disease (AD) is a neurodegenerative disorder, and it is now widely accepted
that neuroinflammation plays a key role in its pathogenesis. Eriodictyol (Eri) and …

Pyroptosis, a lytic form of programmed cell death, both stimulates effective immune
responses and causes tissue damage. Gasdermin (GSDM) proteins are a family of pore …

Alzheimer's disease (AD) is a common, progressive, and devastating neurodegenerative
disorder that mainly affects the elderly. Microglial dysregulation, amyloid-beta (Aβ) plaques …